Epistaxis risk factors

Jump to navigation Jump to search

Epistaxis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epistaxis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epistaxis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epistaxis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epistaxis risk factors

CDC on Epistaxis risk factors

Epistaxis risk factors in the news

Blogs on Epistaxis risk factors

Directions to Hospitals Treating Epistaxis

Risk calculators and risk factors for Epistaxis risk factors

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor in Chief: Liudvikas Jagminas, M.D., FACEP [1] Phone: 401-729-2419

Overview

Occasionally, nosebleeds may indicate other disorders such as bleeding disorders or high blood pressure. Frequent nosebleeds may also be a sign of hereditary hemorrhagic telangiectasia (also called HHT or Osler-Weber-Rendu syndrome). Blood thinners such as Coumadin, Plavix, or aspirin may cause or worsen nosebleeds.

References


Template:WikiDoc Sources